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Coenzyme Q (CoQ) lipids are ancient electron carriers that, in eukaryotes, function in the mitochondrial respiratory chain. In 
mitochondria, CoQ lipids are built by an inner membrane–associated, multicomponent, biosynthetic pathway via successive 
steps of isoprenyl tail polymerization, 4-hydroxybenzoate head-to-tail attachment, and head modification, resulting in 
the production of CoQ. In yeast, we discovered that head-modifying CoQ pathway components selectively colocalize to 
multiple resolvable domains in vivo, representing supramolecular assemblies. In cells engineered with conditional ON 
or OFF CoQ pathways, domains were strictly correlated with CoQ production and substrate flux, respectively, indicating 
that CoQ lipid intermediates are required for domain formation. Mitochondrial CoQ domains were also observed in human 
cells, underscoring their conserved functional importance. CoQ domains within cells were highly enriched adjacent to ER–
mitochondria contact sites. Together, our data suggest that CoQ domains function to facilitate substrate accessibility for 
processive and efficient CoQ production and distribution in cells.
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Introduction
Mitochondria possess a protein-dense inner membrane organized 
into compositionally and morphologically distinct functional do-
mains (Cogliati et al., 2016). The flat inner boundary membrane, 
parallel to the mitochondrial outer membrane, is enriched in mi-
tochondrial protein import machinery (Vogel et al., 2006; Wurm 
and Jakobs, 2006). In contrast, the lamellar-like cristae mem-
brane extends into the matrix and houses the electron transport 
chain complexes (Mannella et al., 1994). Within cristae, ATP syn-
thase dimers bend and stabilize their highly curved edges, and 
respiratory chain complexes further assemble together into large 
megadalton supramolecular complexes, which may contribute to 
both oxidative phosphorylation efficiency and cristae compart-
ment maintenance (Kühlbrandt, 2015). In addition, the MIC OS 
complex assembles on the inner membrane into a scaffold struc-
ture that connects the outer and inner membranes (Rabl et al., 
2009; Harner et al., 2011; Hoppins et al., 2011; von der Malsburg 
et al., 2011; Friedman et al., 2015). Together with the mitochon-
drial lipids cardiolipin and phosphatidylethanolamine, MIC OS is 
thought to determine the copy number of cristae—likely by sta-
bilizing the junctions that connect the boundary and cristae inner 
membrane domains (Friedman et al., 2015).
Metabolic pathways within mitochondria, such as the TCA 
cycle and the pyruvate dehydrogenase complex, also play roles 
in the higher-order organization of the mitochondrial com-
partment by assembling into large complexes or metabolons in 
a spatially defined manner within cells (Brandina et al., 2006; 
Chan et al., 2015; Webb et al., 2017). Proteins in the coenzyme 
Q (CoQ) biosynthetic pathway form a complex associated with 
the mitochondrial inner membrane and synthesize a highly hy-
drophobic prenylated benzoquinone lipid that is an essential 
component of the respiratory chain (Stefely and Pagliarini, 2017; 
Awad et al., 2018). The CoQ lipid functions to transfer electrons 
from respiratory complexes I and II to complex III and facilitates 
H+ pumping across the inner membrane to power ATP synthe-
sis by Complex V. Essential components of the CoQ biosynthetic 
pathway are highly conserved across kingdoms and, in yeast, are 
required for growth on nonfermentable carbon sources, consis-
tent with the essential role of CoQ in respiration (Tzagoloff et al., 
1975; Tzagoloff and Dieckmann, 1990). In humans, mutations in 
genes required for CoQ synthesis cause heterogeneous pheno-
types consistent with mitochondrial respiratory chain deficiency 
(Luna-Sánchez et al., 2015; Acosta et al., 2016). In addition, mouse 
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models of a diverse array of mitochondrial diseases possess CoQ 
synthesis deficiencies, likely via secondary defects in the ex-
pression of CoQ pathway components, further highlighting the 
central role of CoQ biosynthesis in mitochondrial homeostasis 
(Montero et al., 2013; Kühl et al., 2017).
A majority of the CoQ biosynthetic pathway (∼13 compo-
nents) is localized within mitochondria. However, the isoprene 
carbon units that create the CoQ tail and the 4-hydroxybenzo-
ate quinone head precursor, produced from tyrosine, are syn-
thesized by extramitochondrial pathways in the ER and cytosol 
(Fig.  1 A). In yeast, these building blocks are transported into 
mitochondria via unknown mechanisms. Within yeast mito-
chondria, Coq1 polymerizes highly charged isoprene units into 
a 6-unit tail, and Coq2 attaches the 4-hydroxybenzoate head to 
the isoprenyl tail to produce the 4-hydroxy-3-hexaprenyl ben-
zoate (HHB) CoQ lipid intermediate (Ashby et al., 1992; Okada 
et al., 1996; Poon et al., 1997). Subsequently, the HHB head group 
is successively modified in a highly cooperative manner by the 
inner membrane–associated enzymes in the following order to 
produce CoQ6: Coq6, Coq3, Coq5, Coq7, and Coq3 (Barkovich et al., 
1997; Poon et al., 1999; Jonassen and Clarke, 2000; He et al., 2014; 
Ozeir et al., 2015). Additional components play unclear roles in 
CoQ biosynthesis including Coq4, Coq8, Coq9, Coq10, and Coq11 
(Barros et al., 2005; Xie et al., 2012; Lohman et al., 2014; Allan 
et al., 2015). Although their exact mechanism of action has not 
been resolved, bioinformatic, structural, and biochemical data 
indicate that a majority have lipid-binding properties, suggest-
ing a chaperone-like role to promote substrate accessibility for 
the head-modifying enzymes (Rea et al., 2010; Lohman et al., 
2014; Reidenbach et al., 2018). Consistent with this model, the 
ancient, atypical kinase Coq8 is an ATPase whose activity is stim-
ulated by the head groups of CoQ intermediates and the inner 
membrane lipid cardiolipin, suggesting that Coq8 may function 
to extract highly hydrophobic CoQ intermediates (Stefely et al., 
2015, 2016b; Reidenbach et al., 2018). Biochemical and proteomic 
analyses indicate that a subset of CoQ pathway components 
(Coq3–9 and Coq11) interact together in a highly interdependent 
manner to form a multi-subunit complex associated with the ma-
trix side of the inner membrane in yeast and humans (Marbois et 
al., 2005; Tran and Clarke, 2007; Floyd et al., 2016; Stefely et al., 
2016a). Consistent with this, cells lacking even late-acting enzy-
matic components of the CoQ pathway, such as Coq7, accumulate 
the earliest lipid precursor HHB (Poon et al., 1997). However, the 
mechanism underlying the cooperative assembly of the CoQ bio-
synthesis machinery is not understood.
Here, to gain insight into how CoQ pathway components as-
semble, we examined the spatial organization of Coq proteins in 
vivo in yeast. We discovered that after head-to-tail attachment, 
Coq head-modifying proteins form multiple discrete inner mem-
brane domains in cells in a highly cooperative manner dependent 
on CoQ lipid intermediates. Within yeast cells, CoQ domains are 
spatially linked to ER–mitochondria contact sites. CoQ domains 
are also observed in human cells, indicating they possess a highly 
conserved function. Together, our data suggest that the coopera-
tive assembly of CoQ domains at ER–mitochondria contact sites 
promotes access to CoQ lipid intermediates for efficient and pro-
cessive CoQ production and distribution.
Results
Head-modifying Coq proteins localize to domains
To gain insight into the spatial organization of the CoQ biosyn-
thetic complex in vivo, we directly examined the localization 
and distribution of fluorescent protein–tagged versions of Coq 
proteins using fluorescence microscopy in budding yeast (Fig. 1). 
Specifically, we imaged cells grown to log phase coexpressing 
yEGFP-tagged Coq proteins integrated at their endogenous chro-
mosomal loci and mitochondrial-targeted DsRed (mito-DsRed) 
in media containing dextrose. CoQ is essential for growth on 
nonfermentable carbon sources (Fig. S1 A). Thus, the function 
of yEGFP-tagged Coq proteins was assessed by growth of cells 
harboring tagged versions on the nonfermentable carbon sources 
ethanol and glycerol (Fig. S1 A). In addition, CoQ abundance was 
directly measured using liquid chromatography–mass spectrom-
etry (LC-MS) from cellular extracts (Fig. S1 B). Data from these 
assays show that in a majority of cases, growth rate and CoQ 
abundance in cells harboring yEGFP-tagged COQ genes were not 
significantly different from WT cells, indicating that tagged CoQ 
proteins were functional. In contrast, Coq5-yEGFP cells exhib-
ited slow growth and possessed, in comparison to WT cells, the 
relatively lowest CoQ abundance and the highest levels of CoQ 
intermediates 3-polyprenyl-4-hydroxybenzoate (PPHB6) and 
aminated analogue of PPHB6 (PPAB6), which are early lipid CoQ 
intermediates in the pathway (Fig. S1, A–D). These data indicate 
that cells harboring Coq5-yEGFP possess only a partially func-
tional CoQ pathway, which may be a consequence of the require-
ment of the RNA binding protein, Puf3, for native COQ5 mRNA 
targeting and expression (Lapointe et al., 2018).
The tail polymerase Coq1 and head-to-tail attachment protein 
Coq2 catalyze the first two steps in the CoQ biosynthetic path-
way to produce the HHB lipid intermediate, whose head group 
is then processed by Coq6, Coq3, Coq5, Coq7, and Coq3 to pro-
duce CoQ6 (herein referred to as CoQ; Fig. 1 A). Coq1-yEGFP and 
Coq2-yEGFP localized to mitochondria, as previously described, 
with a uniform distribution similar to the mito-DsRed matrix 
marker (Fig. 1 B). In contrast, the yEGFP-tagged head-modifying 
Coq proteins localized to multiple discrete mitochondrial-associ-
ated foci in cells (Fig. 1 B, >25% of cell population, n > 200 cells), 
which we defined provisionally as domains (Fig. 1, B and C). Ad-
ditionally, Coq proteins thought to function more indirectly in 
head modification were either uniformly localized to mitochon-
dria (Coq8 and Coq10), similar to Coq1 and Coq2, or distributed 
within mitochondria in domains (Coq4, Coq9, and Coq11), similar 
to the head-modifying Coq enzymes within mitochondria in cells 
(Fig. 1 B). Previous work reported that ATP synthase components 
also localize to light resolvable regions within mitochondria, rep-
resenting cristae (Jimenez et al., 2014). As shown in Fig. 1 C, under 
our experimental conditions, the distribution of Atp2-mCherry, 
an ATP synthase component and cristae marker, was relatively 
uniform within mitochondria compared with Coq9-yEGFP, 
which localized to discrete mitochondrial regions, indicating 
that the CoQ domains are unique and do not strictly correspond 
to cristae. Previous biochemical analyses of the CoQ biosynthetic 
pathway suggest that a subset of Coq proteins interact to form an 
inner membrane–associated complex (Marbois et al., 2005, 2009; 
Tran and Clarke, 2007; Floyd et al., 2016). Consistent with these 
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Figure 1. Head-modifying Coq proteins localize to mitochondrial domains in vivo. (A) Working model of the yeast CoQ biosynthetic pathway. Coq1 
polymerizes the tail (PPP) from IPP and/or FPP derived from the mevalonate pathway in the mitochondrial matrix. Coq2 attaches PPP to 4-HB, synthesized 
in the cytoplasm, to produce the intermediate CoQ lipid HHB. Coq8 functions to extract CoQ intermediate lipids to facilitate the nucleation of CoQ domains 
containing head-modifying components. CoQ6 is produced by known successive enzymatic modifications of the HHB head by Coq6, Coq3, Coq5, Coq7, and Coq3, 
as indicated by the head color of the associated CoQ lipid intermediates. Coq4, Coq8, Coq9, Coq10, and Coq11 play additional unclear roles in head modification. 
Coq1, Coq2, Coq8, and Coq10 do not localize to CoQ domains at steady state. (B) Representative max z-projection images of yeast cells expressing indicated 
Coq-yEGFP (green) from their endogenous loci and mito-DsRed (red). Percentage of cells with CoQ domains corresponding to respective yeast strains are shown 
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data, domain-localized Coq proteins correspond to the subset of 
complex-associated Coq components, with the exception of Coq8. 
Our observations indicate that components that function in the 
head-group modification part of the CoQ biosynthetic pathway 
were specifically localized to domains (Fig. 1 A).
To gain insight into the properties and composition of CoQ 
domains, we analyzed the number of domains per cell (Fig. 1 D), 
the total domain area (Fig.  1  E), and domain intensity per do-
main area (Fig. 1 F) labeled by each of the domain-localized Coq-
yEGFP proteins. For any given Coq-yEGFP, a comparable average 
number of four to six Coq-yEGFP–labeled domains per cell was 
observed (Fig. 1 C, >200 cells). The exception was the partially 
active Coq5-yEGFP, which labeled on average one domain per cell 
(Fig. 1 C, >80 cells). The average domain area and fluorescence 
intensity per domain area of Coq-yEGFP–labeled domains were 
also comparable among the Coq-yEGFP, suggesting that domains 
comprise all CoQ domain-forming components (Fig. 1, E and F). 
To directly determine if Coq proteins colocalized within domains, 
we examined the localization of a head modifier Coq6-yEGFP and 
a nonenzymatic CoQ component Coq9-mCherry coexpressed in 
cells from their endogenous loci by fluorescence microscopy. Line 
scan analysis revealed that Coq6-yEGFP and Coq9-mCherry lo-
calized together in domains (Fig. 1 G, n = 100 domains, >30 cells). 
Thus, with our characterization (Figs. 1, D–F), these data indicate 
that CoQ domains possess a similar composition within cells.
CoQ domains are conserved in human cells
We asked whether mitochondrial CoQ domains are also found in 
human cells. Specifically, we examined the localization of the na-
tive human Coq9 orthologue using indirect immunofluorescence 
with Alexa Fluor 488–conjugated anti-human COQ9 antibodies 
in human osteosarcoma (U2OS) cells colabeled with mitochon-
drial vital dye, MitoTracker Red. Similar to our observations in 
yeast, endogenous human COQ9 localized to discrete foci that co-
localized with MitoTracker Red (Fig. 2, A and B, 471 ± 52 domains 
per cell, n = 11 cells). To test the specificity of the anti-COQ9 an-
tibody, we overexpressed COQ9-GFP in U2OS cells and observed 
the colocalization of GFP and anti-Coq9 fluorescence (Fig. S1 E). 
Thus, these data indicate that CoQ domains are observed within 
human mitochondria, consistent with the high degree of evolu-
tionary conservation among Coq proteins and underscoring the 
functional importance of CoQ domains.
Functional status of CoQ pathway influences CoQ 
domain copy number
The hypomorphic Coq5-yEGFP mutant labeled fewer and larger 
domains in cells (Fig. 1, D and E), suggesting that the functional 
status of the CoQ pathway influences CoQ domain copy number. 
To test this, we compared Coq5-labeled domains in cells express-
ing endogenous Coq5-yEGFP to cells expressing a fully functional 
13Myc-tagged version of Coq5, as assessed by cell growth on non-
fermentable carbon sources and CoQ abundance in comparison to 
WT cells (Fig. S2, E–H). To detect Coq5-13Myc, we performed indi-
rect immunofluorescence on yeast cells labeled with MitoTracker 
Red using anti-Myc Alexa Fluor 488–labeled antibodies (Fig. S2 
A). As controls, we also examined the localization of functional 
13Myc-tagged versions of Coq6, Coq8, or Coq9 in cells, expressed 
from their endogenous loci. Consistent with the behavior of the 
respective yEGFP-tagged versions, Coq6-13Myc and Coq9-13Myc 
localized to an average of four to six domains per cell, while Coq8-
13Myc was uniformly distributed in mitochondria, compared 
with matrix labeled with MitoTracker Red (Fig. S2 B). However, 
in contrast to Coq5-yEGFP, which localized to an average of one 
to two domains per cell, Coq5-13Myc localized to a significantly 
greater number of domains per cell, similar to cells expressing 
other functional Coq-tagged proteins (Fig. S2, B and D). Taken 
together, these data suggest that the functional status of the CoQ 
pathway determines CoQ domain number and distribution in mi-
tochondria. Alternatively, or in addition, these observations may 
suggest that Coq5 plays a more direct role in CoQ domain assembly.
Essential CoQ biosynthetic components are required for CoQ 
domain formation
We asked which Coq proteins were required for CoQ domain for-
mation by examining the localization of the CoQ domain marker 
Coq9-yEGFP in cells lacking individual COQ genes (Fig. 3). Al-
though the tail polymerase and head-to-tail attachment proteins, 
Coq1 and Coq2, respectively, were not localized to domains, they 
and all of the other essential Coq proteins, Coq3, Coq4, Coq5, 
Coq6, Coq7, and Coq8, were required for formation of Coq9-
yEGFP domains in cells (Fig. 3 A). In contrast, in cells lacking the 
nonessential CoQ components, Coq10 or Coq11, Coq9-labeled do-
mains were observed, albeit in less of the Δcoq10 cell population 
compared with WT (Fig. 3, A and D). The apparent defect in do-
main assembly in Δcoq10 cells correlated with slower growth on 
nonfermentable carbon relative to WT, a phenotype that is tightly 
linked to CoQ production (Fig. S1 A). Coq9 expression was similar 
to WT in cells lacking Coq1, Coq2, Coq3, Coq5, Coq6, Coq7, Coq8, 
and Coq10, as assessed by Western blot analysis and by corrected 
total cell fluorescence, but was reduced in Δcoq4, consistent 
with published observations indicating that Coq4 is required for 
the stable expression of CoQ biosynthetic complex components 
(Fig. 3, B and C; Hsieh et al., 2007; Marbois et al., 2009). In addi-
tion, we observed increased expression of Coq9-yEGFP in Δcoq11 
cells. Although the basis of this increase is not clear, it likely ex-
plains the relatively higher fluorescence intensity per domain 
area observed in Δcoq11 cells relative to WT (Fig. 3 F). Thus, with 
the possible exception of Δcoq4 cells, the absence or reduction 
below images as mean ± SEM; n > 70 cells from three independent experiments. Dotted lines represent cell boundary. (C) Representative max z-projection 
images of yeast cells expressing Coq9-yEGFP (green) and Atp2-mCherry (red) from their endogenous loci. Dotted lines represent cell boundary. (D–F) Quanti-
fication of average number of domains per cell (D), domain area in µm2 (E), and domain intensity per domain area in fluorescence intensity AU per µm2 (F) from 
cells imaged in B. Data represented as mean ± SEM; n > 70 cells from three independent experiments. (D) Kruskal–Wallis test, P = 0.01, followed by Dunn test, 
*, P < 0.02. (E) Kruskal–Wallis test, P = 0.02, followed by Dunn test, not significant. (F) Kruskal–Wallis test, P = 0.09, not significant. (G) Single-plane images 
of yeast cells expressing Coq9-mCherry (red) and Coq6-yEGFP (green). Arrows indicate CoQ domains analyzed by line scan of fluorescence intensity indicated 
by dashed lines. Y axis is fluorescence intensity (AU), and x axis is distance (µm). Scale bars = 2 µm.
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of Coq-labeled domains in cells lacking COQ genes results from 
defective CoQ domain formation per se. The observation that all 
essential CoQ components are required for domain formation is 
consistent with biochemical analysis indicating that the loss of 
any single essential yeast Coq protein destabilizes the CoQ bio-
synthetic complex in cells (He et al., 2014; Stefely et al., 2016a).
CoQ lipid substrates are required for domain formation
Our observations point to a role of CoQ lipid substrates in CoQ do-
main formation. To test this, we engineered a conditional ON CoQ 
pathway in cells and examined CoQ domains in the ON and OFF 
states using the CoQ domain marker, Coq9. Specifically, we used 
a hypomorphic allele of the essential head modifier flavoprotein 
monoxygenase, Coq6 G386A N388D, mutated in conserved resi-
dues implicated in NAD PH and FAD binding (Palfey et al., 1994; 
Eppink et al., 1997; Ozeir et al., 2011). Exogenous addition of van-
illic acid (VA), a dihydroxybenzoic acid derivative, bypasses the 
requirement for enzymatically active Coq6 in CoQ production in 
Coq6 G386A N388D mutant cells and restores CoQ biosynthesis 
and respiration (Ozeir et al., 2011). However, restoration of CoQ 
production in the Coq6 G386A N388D mutant requires the phys-
ical presence of Coq6 G386A N388D and the native biosynthetic 
pathway, suggesting that CoQ biosynthetic complex assembly 
must be preserved for the successful utilization of VA by the CoQ 
pathway (Ozeir et al., 2011).
We examined the distribution of Coq9-yEGFP in Δcoq6 cells 
and in cells expressing WT COQ6 or COQ6 G386A N388D. Coq9-
yEGFP–labeled domains were observed only in Δcoq6 cells ex-
pressing WT Coq6, consistent with the essential role of active 
Coq6 in CoQ domain formation in vivo (Fig. 4 A). To determine 
whether CoQ lipid substrates are required for domain assem-
bly, we examined Coq9-yEGFP distribution after addition of 
exogenous VA for >24 h. In the presence of VA, Coq9-yEGFP–la-
beled CoQ domains were observed in Δcoq6 cells expressing ei-
ther WT Coq6 or the Coq6 G386A N388D mutant (Fig. 4 A). To 
test whether VA-conditional domain formation in Coq6 G386A 
N388D cells was correlated with CoQ biogenesis, we examined 
both CoQ domain formation and CoQ abundance at fixed time 
points 2, 10, and 26 h after VA addition. Consistently, we observed 
an increase in CoQ production over time (Fig. S3, A–C), with a 
corresponding increase in the percentage of cells with Coq9-la-
beled CoQ domains (Fig. S3 D). Both Western blot analysis and 
total cell fluorescence analysis (Fig.  4, B and C, respectively) 
indicated that Coq9-yEGFP expression was not significantly 
different in cells grown in either the presence or absence of VA. 
Thus, changes in Coq9-yEGFP expression did not contribute to 
VA-dependent domain formation. In addition, these data suggest 
that VA-dependent domains form in Coq6 G386A N388D cells by 
the concentration/assembly of the preexisting steady-state pool 
of Coq9-yEGFP. Consistent with this, Coq9-yEGFP intensity per 
domain area in Coq6 G386A N388D cells was threefold greater in 
VA-dependent domains compared with intensity per area for the 
more uniformly distributed Coq9-yEGFP observed within mito-
chondria in a majority of cells in the absence of VA (8 ± 1 vs. 25 ± 
3 × 103 AU/µm2, respectively, n > 300 domains). These observa-
tions indicate that CoQ domains are supramolecular assemblies 
of Coq proteins.
We also examined CoQ domains by performing blue native–
PAGE (BN-PAGE) analysis to examine detergent-soluble native 
Coq9-containing complexes from isolated mitochondria using 
anti-yeast Coq9 antibodies (Fig. S4 A). A >100-kD Coq9-contain-
ing complex was observed by BN-PAGE only in mitochondrial 
detergent extracts from Δcoq6 cells expressing WT Coq6 or from 
Coq6 G386A N388D cells grown in the presence of VA and not 
from either Δcoq6 cells with an empty vector or from Coq6 G386A 
N388D cells grown in the absence of VA (Fig. S4 A). Thus, these 
data support a model in which the recruitment of Coq proteins 
into Coq complexes, supramolecular assemblies, and/or domains 
is dependent on CoQ lipid intermediates formed at biosynthetic 
steps in the CoQ pathway subsequent to HHB synthesis.
To further test this model, we examined domain formation 
in cells engineered with a conditional OFF CoQ pathway. Specif-
ically, we used an “irreversibly sensitized” version of the atypi-
cal kinase Coq8 (Coq8 AS), mutated in the ATP-binding pocket 
(V202C M303C) to allow binding of a halomethyl ketone (CMK; 
Rodríguez-Molina et al., 2016; Reidenbach et al., 2018). CMK spe-
cifically and covalently inhibits Coq8 AS enzymatic activity and 
CoQ production (Reidenbach et al., 2018). In Δcoq8 cells, Coq9-
yEGFP–labeled domains were observed in a comparable popu-
lation of cells expressing either WT Coq8 or Coq8 AS (Fig. 4 D). 
However, upon addition of CMK, a significant decrease in the 
population of cells with Coq9-yEGFP–labeled domains was ob-
served only in cells expressing the Coq8 AS, with no domains de-
tected in a majority of cells after a 2-h CMK incubation (Fig. 4 D). 
In addition, we measured CoQ abundance in conditional OFF cells 
Figure 2. CoQ domains form in human cells. (A and B) Representative 
max z-projection confocal (A) or structured illumination superresolution (B) 
images of fixed U2OS cells labeled with anti-COQ9 antibody conjugated to 
Alexa Fluor 488 (green) and MitoTracker Red (red). Dotted boxes indicate mag-
nified regions in the inset (right). Scale bars = 10 µm (A) and 5 µm (B). Scale 
bars in the inset = 2 µm.
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in the presence and absence of CMK. A relatively small difference 
in CoQ abundance and CoQ intermediates was observed in the ex-
tracts from cells treated with CMK over the course of 2 h in Coq8 
AS cell extracts relative to untreated cells (Fig. S3, E–G). These 
similar levels of CoQ are consistent with the reported long 49–
125-h half-life of CoQ relative to the CMK treatment time (Thelin 
et al., 1992). Given that Coq9-yEGFP–labeled domains dispersed 
within 2 h of CMK treatment, these data suggest that under these 
conditions, CoQ domain formation is dependent on intermediate 
substrates, not CoQ abundance.
Figure 3. Essential Coq proteins are required for CoQ domain formation in cells. (A) Representative max z-projection images of yeast cells expressing 
Coq9-yEGFP (green) from its endogenous loci and mito-DsRed (red) in indicated strains. Percentage of cells with CoQ domains corresponding to respective yeast 
strains are shown below images as mean ± SEM; n > 70 cells from three independent experiments. Dotted lines represent cell boundary. (B) Representative 
Western blot analysis (top) with indicated antibodies from cells expressing Coq9-yEGFP from its endogenous loci of whole-cell lysates from indicated strains. 
G6PDH antibody was used as a loading control. Quantification of the relative density of GFP/G6PDH normalized to WT (bottom) for three independent experi-
ments. Data are represented as mean ± SEM. ANO VA, P = 2.8 × 10−6, followed by pairwise t test, *, P < 0.04, A = P < 0.01 for Δ4 compared with WT, Δ2, Δ3, Δ5, 
Δ6, Δ8, Δ11. (C) Corrected total cell fluorescence of indicated strains from A. ANO VA, P = 2.8 × 10−6, followed by pairwise t test, *, P < 0.002, A = P < 0.04 for Δ4 
compared with WT, Δ1, Δ5, Δ7, Δ11. (D–F) Quantification of average number of domains per cell (D), domain area in µm2 (E), and domain intensity per domain 
area in fluorescence intensity AU per µm2 (F) from cells imaged in A. Data represented as mean ± SEM; n > 70 cells from three independent experiments. (D) 
Kruskal–Wallis test, P = 0.05, not significant. (E) ANO VA, P = 0.01, followed by pairwise t test, *, P < 0.04. (F) ANO VA, P = 0.0001, followed by pairwise t test, 
*, P < 0.001. Scale bars = 2 µm.
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Figure 4. CoQ lipid intermediates are required for CoQ domain formation in cells. (A) Representative max z-projection images of Δcoq6 yeast cells expressing 
Coq9-yEGFP (green) from its endogenous loci, mito-DsRed (red), and empty vector, Coq6 WT, or Coq6 G386A N388D expressed from the TRP locus. Cells were grown 
in media without (top) or with (bottom) 1mM VA for >24 h. Percentage of cells with CoQ domains corresponding to respective yeast strains are shown below images 
as mean ± SEM; n > 70 cells from three independent experiments. Dotted lines represent cell boundary. (B) Representative Western blot analysis (top) with indicated 
antibodies from cells expressing Coq9-yEGFP from its endogenous loci of whole-cell lysates from indicated strains in A. G6PDH antibody was used as a loading control. (C) 
Corrected total cell fluorescence of indicated strains from A in the absence (gray) and presence (dark gray) of VA. n > 70 cells from three independent experiments. Data 
represented as mean ± SEM. Two-way ANO VA, P = 0.9, 0.9, 1.0, not significant. (D) Representative max z-projection images of Δcoq8 yeast cells expressing Coq9-yEGFP 
(green) from its endogenous locus, mito-DsRed (red), and empty vector, Coq8 WT, or Coq8 V202C M303C (Coq8 AS) expressed from a 2-µm plasmid. Cells were grown 
to log phase in media without (top) or with (bottom) 1 mM CMK for indicated times. Percentage of cells with CoQ domains corresponding to respective yeast strains are 
shown below images as mean ± SEM; n > 70 cells from three independent experiments. Dotted lines represent cell boundary. Scale bars = 2 µm.
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CoQ lipid intermediates are highly hydrophobic. Thus, we con-
sidered the possibility that CoQ domains function to promote the 
maintenance of substrate accessibility for efficient and proces-
sive head modification by essential head-modifying CoQ pathway 
components. Consistent with this idea, many of the “non-enzy-
matic” CoQ pathway components possess lipid-binding activities 
and may play lipid chaperone roles (Rea et al., 2010; Lohman et al., 
2014; Reidenbach et al., 2018). One such component is Coq8, whose 
ATPase activity is stimulated by both cardiolipin and CoQ interme-
diate head groups, suggesting that Coq8 powers CoQ intermediate 
lipid extraction from the inner membrane to facilitate modifica-
tion by head-modifying Coq enzymes (Reidenbach et al., 2018). 
Consistently, it was previously shown that overexpression of Coq8 
suppressed CoQ biosynthetic complex assembly defects caused by 
mutation or absence of Coq5, Coq6, Coq7, or Coq9 and supported 
production of CoQ pathway intermediates, but not of terminal CoQ 
production (Xie et al., 2012; He et al., 2014). Thus, to further test 
the connection between domain formation and CoQ production and 
the role of CoQ lipid intermediates, we asked whether a multicopy 
plasmid containing COQ8 with its endogenous promoter (pRS424: 
COQ8) also suppressed defects in CoQ domain formation observed 
in cells lacking essential CoQ biosynthetic components (Fig. 5).
We imaged Coq9-yEGFP in Δcoq1, Δcoq2, Δcoq3, Δcoq4, Δcoq5, 
Δcoq6, Δcoq7, and Δcoq8 cells containing pRS424: COQ8. In the 
presence of pRS424: COQ8, Coq9-yEGFP–labeled domains were 
observed in Δcoq8 cells, as expected, and also in Δcoq5, Δcoq6, 
and Δcoq7 cells (Fig. 5 A). However, the addition of pRS424: COQ8 
failed to suppress domain assembly defects in Δcoq1, Δcoq2, Δcoq3, 
and Δcoq4 cells (Fig. 5 A). These data correlate with previous bio-
chemical data examining the effect of Coq8 overexpression in coq 
mutants on CoQ complex assembly and CoQ lipid intermediate 
production (Xie et al., 2012; He et al., 2014). pRS424: COQ8 also 
suppressed Coq4-yEGFP and Coq6-yEGFP domain formation de-
fects in Δcoq5, Δcoq8, and Δcoq9, but not in Δcoq1, cells (Fig. 5 B), 
indicating that the effect of pRS424: COQ8 was not specific to Coq9-
yEGFP domains. These observations are consistent with a role of 
CoQ lipid substrates in CoQ domain formation. Also consistent 
with this model is the failure of pRS424: COQ8 to suppress domain 
formation defects in Δcoq1 and Δcoq2 cells with pRS424: COQ8, as 
these cells lack CoQ intermediate lipids. For Δcoq3 and Δcoq4 cells, 
however, the failure to suppress the CoQ domain formation defect 
is likely a consequence of their respective distinctive functions in 
the CoQ pathway. Coq3 uniquely functions at both an early and a 
late step in the CoQ biosynthesis, which is arguably a more severe 
biosynthetic defect. However, it is also possible that the lack of sup-
pression indicates that Coq3, like Coq4, functions in Coq protein 
complex assembly. Coq4 is important for CoQ biosynthetic com-
ponent stability—a phenotype that is apparent from loss of Coq9-
yEGFP in Δcoq4 cells (Figs. 3 B and 5 A) via a scaffolding role in 
complex assembly (Marbois et al., 2009). Together, these data are 
consistent with a role of CoQ domains in the maintenance of CoQ 
lipid intermediate accessibility from the inner membrane.
CoQ domains are spatially linked to ER–
mitochondria contact sites
Our observations indicate that WT cells contain multiple mito-
chondrial CoQ domains. To examine whether CoQ domains are 
randomly distributed within mitochondria, we examined their 
spatial localization relative to ER–mitochondria contact sites, 
which we have previously shown to function as a nonrandom 
distribution mechanism for mitochondrial division machinery 
and replicating mtDNA nucleoids (Murley et al., 2013; Lewis 
et al., 2016). Two redundant ER–mitochondria tethers exist in 
yeast: Ltc1, a membrane sterol transporter protein localized to 
the ER, which partners with the mitochondrial outer membrane 
protein Tom71, and the multicomponent ERM ES complex, which 
is thought to facilitate the transport of phospholipids between 
mitochondria and the ER (Kornmann et al., 2009; Elbaz-Alon et 
al., 2015; Gatta et al., 2015; Murley et al., 2015). Previous work has 
shown that both Ltc1 and ERM ES components localize to punc-
tate structures at regions of ER–mitochondria contact; however, 
ERM ES marks only a subset of contacts (Murley et al., 2015). 
Thus, we labeled ER–mitochondria contacts using a functional 
yEGFP-tagged version of Ltc1 and observed that a vast major-
ity of CoQ domains labeled with Coq9-yEcherry were spatially 
linked to Ltc1-yEGFP foci (Fig. 6 A, 76%, n = 467 domains and 243 
cells). Consistent with this, Coq9-yEGFP–labeled domains were 
also spatially linked to regions of ER tubules, labeled with HDEL-
DsRed, that were adjacent to mitochondria, labeled with the ma-
trix marker mito-TagBFP (Fig. 6 B). These observations suggest 
that ER–mitochondria contacts may serve to specify regions of 
the mitochondrial inner membrane for CoQ domain formation 
and distribution.
We examined the roles of ER–mitochondria contact site 
components, Ltc1 and the related Ltc family members, Ltc2–4, 
and Mmm1, which is an essential ERM ES component, in CoQ 
domain formation and distribution and CoQ production. We 
did not observe any significant differences in the distribution 
or copy number of Coq9-yEGFP–labeled CoQ domains within 
the tubular mitochondrial network, as labeled by mito-dsRed, 
or CoQ production in Δltc1, Δltc1ltc2, or Δltc1ltc2ltc3ltc4 cells 
compared with WT, consistent with their WT growth rates on 
nonfermentable carbon (Elbaz-Alon et al., 2015; Murley et al., 
2015; Fig. S5). ERM ES deletion mutants possess abnormal large 
mitochondrial spheres, have severe growth defects on both fer-
mentable and nonfermentable carbon sources, and lose mtDNA 
at a high frequency (Kornmann et al., 2009). In cells lacking 
ERM ES components, these severe phenotypes rapidly select for 
dominant suppressor mutations, which map to the VPS13 gene 
(Lang et al., 2015). Thus, to avoid pleiotropic indirect effects and 
to examine more direct effects of the loss of Mmm1 function, we 
examined CoQ domains labeled by Coq9-yoHalo in the mmm1-1 
temperature-sensitive mutant, expressing the mitochondrial 
outer membrane protein Tom71-yEGFP under permissive and 
acute (2 h) nonpermissive conditions. Under both permissive 
and nonpermissive conditions, we observed a decrease in the 
percentage of mmm1-1 cells containing CoQ domains relative to 
WT cells (Fig. 7 A). These data are consistent with the mmm1-1 
allele being hypomorphic, as indicated by cells at permissive 
temperature (RT) containing large mitochondrial spheres char-
acteristic of loss of ERM ES function (Fig. 7 A, left panel at RT). 
Deletion of LTC1 enhanced the CoQ domain formation defect 
observed in mmm1-1 cells under the nonpermissive condition 
(Fig.  7  A). Additionally, under nonpermissive conditions, the 
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number of domains per cell decreased, with an associated in-
crease in domain intensity in mmm1-1 and mmm1-1Δltc1 cells 
(Fig. 7, B–D). As expected, CoQ levels were not significantly dif-
ferent in mutant cells under any condition, including the rel-
atively short duration of nonpermissive treatment (Fig.  7  E). 
However, there was an increase in CoQ intermediates that cor-
related with the loss and alteration observed in CoQ domains in 
mmm1-1 and mmm1-1Δltc1 cells under permissive and nonper-
missive conditions (Fig. 7, F and G). In addition, mmm1-1 and 
mmm1-1Δltc1 mutant cells that contained CoQ domains pos-
sessed an average of only one per cell, often localized within a 
single spherical mitochondria, in contrast to an average of four 
domains per WT cell (Fig. 7, A and B). These data suggest that ER–
mitochondria contact sites are important for CoQ domain forma-
tion and CoQ production and may be important for normal CoQ 
domain distribution within cells. However, the exact mechanism 
underlying the role of ER–mitochondria contact sites in the CoQ 
pathway remains to be elucidated.
Figure 5. Coq8 overexpression suppresses defective CoQ domain formation in the absence of specific Coq proteins in cells. (A) Representative max 
z-projection images of yeast cells expressing Coq9-yEGFP (green) from its endogenous loci, mito-DsRed (red), and containing pRS424 or pRS424: COQ8 in 
indicated strains. Percentage of cells with CoQ domains corresponding to respective yeast strains are shown below images as mean ± SEM; n > 70 cells from 
three independent experiments. Dotted lines represent cell boundary. (B) Representative max z-projection images of yeast cells expressing Coq4-yEGFP (green) 
or Coq6-yEGFP (green) from their endogenous loci, mito-DsRed (red), and containing pRS424 or pRS424: COQ8 in indicated strains. Percentage of cells with 
domains corresponding to images above are represented as mean ± SEM; n > 70 cells from three independent experiments. Scale bars = 2 µm.
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Discussion
Our data show that head-modifying proteins in the CoQ biosyn-
thetic pathway selectively form light-resolvable, supramolecu-
lar assemblies or domains in cells. In this manner, CoQ domain 
assembly is analogous to other multicomponent metabolic path-
ways, such as the de novo purine nucleotide biosynthetic path-
way, the TCA cycle, and the glycolytic pathway, that dynamically 
assemble into metabolons in response to substrates and other 
regulatory inputs (Chan et al., 2015; Webb et al., 2017). Metab-
olons are thought to function as microenvironments that se-
quester pathway intermediates for processive modification and 
prevent intermediates from participating in other metabolic 
pathways (Sweetlove and Fernie, 2018). Given that CoQ lipid 
intermediates are extremely hydrophobic, their accessibility to 
enzymes operating at the aqueous/lipid bilayer interface is likely 
to be rate limiting at every step in CoQ production. Thus, we pos-
tulate that one primary function of CoQ domains is to create and 
maintain a relatively high concentration of accessible CoQ lipid 
intermediates for the efficient and processive production of the 
quinone head group—an idea supported by the strict correlation 
we observe between domain formation and CoQ production. Our 
data indicate that CoQ domain formation requires CoQ lipid in-
termediates formed after HHB, the earliest lipid substrate in the 
pathway, consistent with published work indicating that cells 
accumulate HHB in the absence of acting enzymes in the path-
way (Poon et al., 1997; He et al., 2014). The functional importance 
of CoQ domains is underscored by our observation that they are 
conserved from yeast to human cells. Given the link between 
defects in CoQ production and divergent mammalian mitochon-
drial diseases, our findings raise the possibility that CoQ domains 
also may be a robust biomarker for functional CoQ production in 
human cells, which might enable a deeper understanding of the 
role of CoQ biogenesis defects in human diseases.
Our data provide mechanistic insights into CoQ domain for-
mation and a working model for CoQ biosynthesis (Fig. 1 A). We 
speculate that the highly cooperative assembly of CoQ domains 
requires the coordinate binding of CoQ lipid intermediates by Coq 
proteins and Coq protein scaffolds that function to concentrate 
and organize Coq enzymes responsible for modifying the lipid 
head group. Published work suggests that Coq8 facilitates head 
group modification by mediating the extraction of CoQ inter-
mediate lipids from the inner membrane: it is an ATPase whose 
activity is stimulated by both CoQ head intermediates and the 
mitochondrial inner membrane lipid, cardiolipin (Reidenbach 
et al., 2018). In our analysis, Coq8 behaved as an outlier relative 
to other components that function in the CoQ head modification 
part of the pathway, as it did not concentrate in CoQ domains. As 
such, our data suggest that Coq8 is not a steady-state component 
of the CoQ complex and are consistent with a role as a CoQ lipid 
“chaperone” whose activity is permissive for CoQ domain nucle-
ation and maintenance. Published work on Coq4 suggests that 
it may assist with complex scaffolding: it interacts with Coq3, 
Coq6, and Coq9 (Marbois et al., 2005; Allan et al., 2015). Consis-
tent with a Coq4 protein scaffolding role, overexpression of Coq8 
Figure 6. CoQ domains are spatially linked 
to ER–mitochondria contact sites in cells. 
(A) Single-plane images of yeast cells express-
ing Coq9-mCherry (red), Ltc1-yEGFP (green), 
and mito-TagBFP (blue). Arrows indicate regions 
analyzed by line scan of fluorescence intensity 
indicated by dashed lines. Y axis is fluorescence 
intensity (AU), and x axis is distance (µm). (B) 
Single-plane superresolution images of yeast 
cells expressing Coq9-yEGFP (green), ER-DsRed 
(ER, red), and mito-TagBFP (mitochondria, blue). 
Arrows indicate regions analyzed by line scan of 
fluorescence intensity indicated by dashed lines. 
Y axis is fluorescence intensity (AU), and x axis is 
distance (µm). Scale bars = 2 µm.
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failed to suppress CoQ domain formation defects in Δcoq4 cells. 
In addition, an x-ray structure of a related Coq4 domain in the 
cyanobacteria protein Alr8543 revealed a hydrophobic binding 
pocket containing a geranylgeranyl monophosphate lipid, sug-
gesting that Coq4 may coordinately bind the long isoprenyl tail 
of CoQ intermediates and head modification enzymes (Rea et al., 
2010). Indeed, higher molecular species containing Coq9 were 
only detected by BN-PAGE in the presence of CoQ lipid interme-
diates, further indicating that CoQ lipid production and CoQ do-
main assembly may be obligatorily coupled.
Our data indicate that within mitochondria in cells, CoQ do-
mains are positioned nonrandomly adjacent to ER–mitochon-
dria contacts. Cells defective in ER–mitochondria contact site 
components displayed defects in CoQ domain copy number and 
distribution and accumulated CoQ intermediates. Although the 
molecular basis of the link between CoQ domains and the ER is 
not known, these observations suggest a role for ER–mitochon-
dria contacts in CoQ domain formation and CoQ production and 
distribution. Active positioning of other metabolons at defined 
subcellular localizations has been observed, such as the local-
ization of the cytosolic de novo purine nucleotide biosynthetic 
and glycolytic metabolons adjacent to mitochondria (French 
et al., 2016; Kohnhorst et al., 2017; Pedley and Benkovic, 2017). 
In these cases, the colocalization is thought to fuel and coordi-
nate metabolic pathways via the exchange of substrates, cofac-
tors, and products. The spatial organization of the mevalonate 
pathway, which produces the isoprene units used inside mito-
chondria for Coq1-dependent tail polymerization, has not been 
fully established. However, many components of this pathway, 
including HMG-CoA reductase, are localized to the ER. Thus, it 
is possible that CoQ domains are positioned at the contacts as a 
consequence of substrate flux; however, Coq1 and Coq2, which 
directly use the isoprene units, are not enriched at CoQ domains. 
Alternatively, ER–mitochondria contacts may enrich regions of 
Figure 7. ER–mitochondria contact site components are important for CoQ domain formation and distribution. (A) Representative max z-projection 
images of yeast cells expressing Coq9-yoHalo (magenta) and Tom71-yEGFP (green) from their endogenous loci in indicated strains. Cells were grown at RT or 
37°C for 2 h. Percentage of cells with CoQ domains corresponding to respective yeast strains are shown below images as mean ± SEM; n > 70 cells from three 
independent experiments. Dotted lines represent cell boundary. (B–D) Quantification of average number of domains per cell (B), domain area in µm2 (C), and 
domain intensity per domain area in fluorescence intensity AU per µm2 (D) from cells imaged in A. Data represented as mean ± SEM; n > 70 cells from three 
independent experiments. (E–G) Relative CoQ (E), PPAB6 (F), and PPHB6 (G) abundance measurements of indicated strains. Abundance measurements were 
normalized to the corresponding WT at each temperature. Bars represent mean of two independent experiments, and data points (circles) represent the mea-
surements for each experiment. Scale bars = 2 µm.
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associated inner membrane in specific proteins and lipids, such 
as cardiolipin, that modulate the activity of Coq8 and recruit ad-
ditional Coq proteins (Lohman et al., 2019). Our previous work 
has demonstrated that ER–mitochondria contacts link the distri-
bution of mitochondria and mtDNA (Murley et al., 2013; Lewis 
et al., 2016). In this manner, ER–mitochondria contacts may also 
function to spatially organize and integrate essential mitochon-
drial structures. Thus, they could similarly function to control 
the spatial organization of CoQ domains to distribute the CoQ 
lipid within mitochondria to drive oxidative phosphorylation 
and within cells to extramitochondrial compartments, where 
it may play additional redox-related roles (Zhang et al., 1996; 
Fernández-Ayala et al., 2005).
Materials and methods
Plasmid and strain construction
Saccharomyces cerevisiae strains constructed in this study are 
based on the W303 (ade2-1; leu2-3; his3-11, 15; trp 1-1; ura3-1; can1-
100) genetic background. All deletions were derived using PCR-
based homologous recombination replacing the entire ORF of 
targeted genes with NatMX6 cassettes (Longtine et al., 1998; Sheff 
and Thorn, 2004; Hoppins et al., 2011). All C-terminal tags were 
generated using PCR-based targeted homologous recombination 
using the following cassettes: yEGFP::SpHIS5, mCherry::SpHIS5, 
and yoHalo::CaUra3. Strains were constructed by mating and/
or by direct transformation using the lithium acetate method. 
Correct targeting of chromosomal integrations was confirmed 
by PCR. The N-terminal fluorescent protein fusion allele of Coq7 
was generated using the Delitto Perfecto system previously de-
scribed (Storici and Resnick, 2006; Stuckey et al., 2011; Stuckey 
and Storici, 2013). The GSKU cassette was PCR amplified from 
pGSKU, integrated into Coq7 locus by homologous recombina-
tion between amino acids 36 and 37, and verified by PCR. yEGFP 
was PCR amplified and integrated by homologous recombination 
to replace the GSKU cassette. Loss of the GSKU cassette was se-
lected for by growth on 5-fluoroorotic acid. The resulting strain 
was mated back to W303, sporulated, and selected by fluorescence 
microscopy. Haploid double-tagged or deletion strains express-
ing Coq9-yEGFP::His were constructed by crossing followed by 
sporulation or PCR-based targeted homologous recombination. 
The temperature-sensitive allele mmm1-1 expressing Coq9-yo-
Halo::CaUra3 and Tom71-yeGFP::His was constructed by mating 
mmm1-1 Tom71-yeGFP::His or mmm1-1 Δltc1::Nat Tom71-yeGFP:: 
His to Coq9-yoHalo::CaUra3, followed by sporulation.
To generate pRS304-COQ6, genomic DNA from W303A yeast 
strain was used to amplify a PCR product containing COQ6 plus 
its native promoter (∼500 bp 5′ of start codon) and ∼500 bp after 
its stop codon and was then cloned into linearized pRS304 using 
a Gibson isothermal assembly reagent according to the manufac-
turer’s instructions. This plasmid was used to generate pRS304-
COQ6 G386A N388D by isothermal assembly of PCR products that 
when recombined, included the two nucleotide changes. pRS304-
COQ6 plasmids were integrated at the TRP1 locus and introduced 
by linearization using Bsu36I and lithium acetate transformation, 
followed by selection on SD media-Trp agar plates. To generate 
pRS424-COQ8, genomic DNA from W303A yeast strain was used 
to amplify a PCR product containing COQ8 plus its native promoter 
(∼500 bp 5′ of start codon) and ∼500 bp after its stop codon and 
was then cloned into linearized pRS424 using a Gibson isother-
mal assembly reagent according to the manufacturer’s instruc-
tions. pRS426-GPD, pRS426-GPD-COQ8, and pRS426-GPD-COQ8 
M202C were previously described in more detail (Reidenbach et 
al., 2018). To generate pFA6a-yoHalo::CaUra3, yoHalo-Tag plas-
mid was a gift of B. Glick (University of Chicago; Day et al., 2018) 
and was used to amplify a PCR product containing yoHalo. yEGFP 
was cut out of pFA6a-yEGFP::CaUra3 using PacI and AscI and re-
placed with yoHalo using a Gibson isothermal assembly reagent 
according to the manufacturer’s instructions.
pVT100U-mtTagBFP, a 2-µm plasmid driving mitochondrial 
matrix-targeted TagBFP (mt-TagBFP) expression (Friedman et 
al., 2018); pYX142-mtDsRed and pYX142-mtGFP, a CEN/ARS plas-
mid driving mitochondrial matrix-targeted DsRed (mt-dsRed) or 
GFP (mtGFP) expression from a TDI promoter (Westermann and 
Neupert, 2000); and pK1803 (DsRed-HDEL), which expresses a 
fusion protein containing the Kar2 signal sequence, DsRed, and 
an HDEL retention sequence (Madrid et al., 2006) are all previ-
ously described in more detail.
Human CoQ9 was cloned from HCT116 cDNA using Platinum 
SuperFi DNA polymerase (Thermo Fisher Scientific). The CoQ9 
gene was then PCR amplified with the primers 5′-CGA CGG TAC 
CGC GGG CCC GGA TGG CGG CGG CGG CGG TATC-3′ and 5′-CAC CAT 
GGT GGC GAC CGG TGA GCT TCC TCC GCC CCG ACG CTG GTT TAG 
ACC TGT CAA GTT CT-3′ and inserted into a BamHI-digested pEG-
FP-N1 backbone using Gibson isothermal assembly reagent ac-
cording to the manufacturer’s instructions.
Yeast growth assays
Cells were grown to log phase in yeast extract peptone dextrose 
(YPD), pelleted, and resuspended in water at a concentration of 
0.5 OD600/ml. 4 µl of 10-fold serial dilutions were plated on YPD 
and yeast extract, peptone, ethanol, glycerol (YPEG) plates. Cells 
were grown for ∼48 h (YPD) and ∼48–60 h (YPEG) at 30°C.
Fluorescence microscopy
For all fluorescence microscopy experiments with yeast, cells 
were grown at 30°C to log phase in the appropriate synthetic 
medium to select for plasmids. Cells were mounted and imaged 
on a glass-bottom SensoPlate (Greiner 655892) pretreated with 
concanavalin A (C2010, 0.25 mg/ml; Sigma-Aldrich) for 1 h fol-
lowed by drying. Cells were imaged at 25°C.
For VA treatments in Fig.  4, cells were grown in synthetic 
media with Dex–Leu to mid-log phase and incubated in the 
presence or absence of 1 mM VA (Sigma-Aldrich) for the entire 
growth in liquid media. For fixed time points in Fig. S3, mid-log 
phase cells were grown in the absence or presence of 1 mM VA for 
0, 2, 10, or 26 h. For CMK treatments in Fig. 4, cells were grown 
overnight and to mid-log phase in synthetic media with Dex–
Leu–Ura and 10–12 h in synthetic media without pABA and folate 
with Dex–Ura. For fixed time points, cells were grown to mid-log 
phase and incubated for 0.5 or 2 h in the absence or presence of 
1 mM CMK (Reidenbach et al., 2018).
For temperature-sensitive experiments in Fig. 7, cells were 
grown in synthetic media with Dex Complete to mid-log phase 
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at RT and incubated at RT or 37°C for 2 or 24  h. To visualize 
Coq9-yoHalo, JF646 ligand, provided by L. Lavis (Janelia Research 
Campus; Grimm et al., 2015), was added to cells to a final concen-
tration of 1 µM, incubated at RT or 37°C for 30 min, and rinsed in 
synthetic media with Dex Complete, similar to previous descrip-
tion (Day et al., 2018).
For confocal microscopy, images of Z-series (step size of 0.2 
µm) of cells were collected using the spinning-disk module of a 
Marianas SDC Real Time 3D Confocal-TIRF microscope (Intelli-
gent Imaging Innovations) fitted with a 100× 1.46 NA objective 
and a Photometrics QuantEM EMC CD camera. Images were 
captured with SlideBook (Intelligent Imaging Innovations), and 
linear adjustments were made using ImageJ (National Insti-
tutes of Health).
For confocal microscopy for VA time-course experiments in 
Fig. S3, images of Z-series (step size of 0.2 µm) of cells were col-
lected using the Nikon High Content Analysis microscope with 
spinning-disk confocal (Nikon Instruments) fitted with a 100× 
1.46 NA objective and an ORCA-Flash 4.0 V2 Digital CMOS cam-
era. Images were captured with NIS-Elements (Nikon).
For structured illumination superresolution microscopy, cells 
were grown to log phase, concentrated by centrifugation, and 
directly mounted and imaged on MIC RO slides (VWR 48300-
025). Images of Z-series (step size of 0.5  µM) of cells were 
collected using the Nikon Structured Illumination Super-Reso-
lution Microscope (N-SIM) fitted with a 100× 1.46 NA objective. 
Images were captured in the 3D-SIM mode using NIS-Elements 
(Nikon), and SIM processing was performed using the SIM mod-
ule in the Nikon software package. Linear adjustments were 
made using ImageJ.
Indirect immunofluorescence in yeast cells
In Fig. S2, yeast cells were grown in YPD media to log phase and 
incubated with 500 nM MitoTracker Red CMX Ros (Thermo 
Fisher Scientific) according to the manufacturer’s instructions 
for 30 min, protected from light. Fixed as previously described 
(Swayne et al., 2009), cells were washed in YPD media and grown 
for 1 h in 3.7% PFA in YPD media at 30°C. Cells were centrifuged 
and resuspended in Tris/DTT (0.1 M Tris-SO4, pH 9.4, and 0.01 M 
DTT) and incubated for 20 min at 30°C. Cells were centrifuged, 
resuspended in zymolyase 20T (5 mg/ml) in wash solution 
(0.025 M potassium phosphate, pH 7.5, and 0.8 M KCl), and in-
cubated for 20 min at 30°C. Cells were centrifuged, washed two 
times in NS+ (0.02 M Tris-HCl, pH 7.5, 0.04 g/ml sucrose, 1 mM 
EDTA, pH 8.0, 1 mM MgCl2, 0.1 mM ZnCl2, 0.05 mM CaCl2, 1 mM 
PMSF, and 1% wt/vol NaN3), and resuspended in 2 vol of NS+. 
Spheroplasts were used for indirect immunofluorescence. Cells 
were mounted and imaged on glass-bottom SensoPlate (Greiner 
655892) pretreated with Polylysine solution (C2010, 0.25 mg/ml; 
Sigma-Aldrich) for 1 h followed by drying. Cells were incubated 
with primary anti-Myc antibody (Thermo Fisher Scientific) at 
1:200 for 2 h and with Alexa Fluor–conjugated secondary anti-
body (Thermo Fisher Scientific) at 1:1,000. Cells were washed 
with PBT (PBS containing 1% wt/vol BSA, 0.1% Triton X-100, and 
0.1% wt/vol sodium azide) between antibody incubations. Before 
imaging, mounting solution (0.1% wt/vol p-phenylenediamine 
and 90% vol/vol glycerol in PBS) was added to cells.
Mammalian cell growth, transfection, and indirect 
immunofluorescence
For Fig. 2, U2OS cells were grown in high-glucose DMEM supple-
mented with 10% FBS and 1% penicillin/streptomycin. Cells were 
seeded at ∼0.25 × 105 cells per ml in 35-mm glass-bottom dishes 
(Mattek) and allowed to attach for 24 h before mitochondrial stain-
ing with 500 nM MitoTracker Red CMX Ros (Thermo Fisher Sci-
entific) according to manufacturer instructions. Cells were then 
directly fixed in 4% PFA in PBS, pH 7.4, for 20 min at RT, protected 
from light. Dishes were washed twice in PBS, permeabilized in 
0.1% Triton X-100 for 20 min, and blocked in 3% BSA PBS solution 
for 1 h at RT. Primary anti-Coq9 antibodies (ProteinTech) were 
added at 1:10,000 in PBST (PBS, pH 7.4, 1% BSA, and 0.1% Tween-
20) overnight at 4°C, rinsed three times in PBS and incubated with 
Alexa Fluor–conjugated secondary antibodies (Thermo Fisher Sci-
entific) at 1:2,000 dilution in PBST for 1 h. Dishes were washed 
at least three times before imaging. Imaging was performed as 
previously described above using the spinning-disk module of an 
inverted objective fluorescence microscope or Nikon Structured 
Illumination Super-Resolution Microscope.
For Fig. S1 E, the day before transfection, U2OS cells were 
plated on 12-mm coverslips (#1.5) in a 24-well plate at a density 
of 75,000 cells per well. Transfection was performed with Lipo-
fectamine 2000 (Thermo Fisher Scientific) according to the man-
ufacturer instructions using 25 ng of FUGW-CoQ9-eGFP plasmid, 
175 ng of pGEM 3Z f(+) plasmid as carrier DNA, and 1.25 µl of 
Lipofectamine 2000 per well. Cells were fixed and imaged as pre-
viously described above using the spinning-disk module of an 
inverted objective fluorescence microscope.
Lipid extraction
Cells were grown to log phase in YPD or appropriate synthetic 
media with Dex to select for plasmids, centrifuged, and flash-fro-
zen dropwise in liquid N2. Frozen pellets of yeast (108 cells) were 
thawed on ice and mixed with glass beads (0.5 mm diameter, 
100 µl). CHCl3/MeOH (2:1, vol/vol, 4°C, 900 ml) and CoQ10 (10 µl, 
10 µM, 0.1 nmol) were added and vortexed (2 × 30 s). HCl (1 M, 
200 µl, 4°C) was added and vortexed (2 × 30 s). The samples were 
centrifuged (5,000 g, 2 min, 4°C) to complete phase separation. 
400 µl of the organic phase was transferred to a clean tube and 
dried under Ar(g). The organic residue was reconstituted in ACN/
IPA/H2O (65:30:5, vol/vol/vol, 100 µl) for LC-MS analysis.
LC-MS lipid analysis
LC-MS analysis was performed on an Acquity CSH C18 column 
held at 50°C (100 mm × 2.1 mm × 1.7 µm particle size; Waters) using 
a Vanquish Binary Pump (400 µl/min flow rate; Thermo Fisher 
Scientific). Mobile phase A consisted of 10 mM ammonium acetate 
in ACN: H2O (70:30, vol/vol) containing 250 µl/l acetic acid. Mobile 
phase B consisted of 10 mM ammonium acetate in IPA: ACN (90:10, 
vol/vol) with the same additives. Mobile phase B was initially held 
at 50% for 1.5 min and then increased to 99% over 7.5 min and held 
there for 2 min. The column was reequilibrated for 2.5 min before 
the next injection. 10 µl of samples were injected by a Vanquish 
Split Sampler HT autosampler (Thermo Fisher Scientific).
The LC system was coupled to a Q Exactive mass spectrome-
ter by a HESI II heated ESI source maintained at 300°C (Thermo 
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Fisher Scientific). The inlet capillary was kept at 300°C, sheath 
gas was set to 25 units and auxiliary gas to 10 units, and the spray 
voltage was set to 5,000 V. For identification of CoQ6, the MS was 
operated in positive mode, and a mass of 591.44 was targeted for 
fragmentation. Automatic gain control (AGC) target was set to 5 
× 105, and resolving power was set to 140,000. Quantification was 
performed in Xcalibur (Thermo Fisher Scientific) by monitoring 
the product ion 197.08 Th, corresponding to the Q headgroup, for 
each targeted mass. The MS was operated in negative mode, and 
masses (545.40 and 544.42, respectively) were targeted to quan-
tify CoQ intermediates PPHB6 and PPAB6. AGC target was set to 
5 × 105, and resolving power was set to 140,000.
Whole-cell extracts and mitochondrial isolation
For whole-cell extracts, cells were grown to log phase in YPD or 
synthetic complete media with Dex or Leu to select for plasmids. 
Whole-cell lysates of 0.25 OD600 cells were obtained by alkaline 
extraction (0.255 M NaOH and 1% β-mercaptoethanol), precip-
itated with 9% trichloroacetic acid, washed with acetone, dried, 
and resuspended in 50 µl MURB protein sample buffer (100 mM 
MES, pH 7.0, 1% SDS, 3 M urea, and 10% β-mercaptoethanol). 
10 µl of sample was used for Western blot analysis.
For isolation of mitochondria, cells were grown to log phase 
in synthetic complete media with Dex or Leu to select for plas-
mids. Cells were grown to log phase, and 500 OD600 cells were 
centrifuged at 2,700 rpm. Cell pellets were washed with water, 
resuspended in NMIB (0.6 M sorbitol, 20 mM Hepes, 100 mM 
KOAc, 5 mM MgCl2, 50 mM KCl, and 1 mM PMSF) and 1× Protease 
Inhibitor Mixture I (Calbiochem), flash-frozen dropwise in liq-
uid N2, and lysed using a Freezer/Mill (SPEX). Cell lysates were 
centrifuged at 4,500 rpm for 5 min, and supernatant was cen-
trifuged at 10,500 rpm for 15 min. Pellets were resuspended in 
400 µl NMIB with Inhibitor Mixture I. 25 µg protein, determined 
by Bradford or BCA assay, was added to MURB sample buffer and 
used for Western blot analysis.
Western blot analysis
Samples were boiled for 5 min, analyzed by SDS-PAGE, trans-
ferred to nitrocellulose, and immunoblotted with primary anti-
bodies at indicated concentrations: anti-GFP antibody (1:2,000, 
University of California, Davis, NeuroMab clone N86/8), an-
ti-Coq4 antibody (Belogrudov et al., 2001), anti-Coq9 antibody 
(Hsieh et al., 2007), anti-GP6DH antibody (1:2,000, Sigma-Al-
drich), and anti-Porin antibody (1:5,000, Thermo Fisher Sci-
entific). The appropriate secondary antibodies conjugated to 
DyLight680 or DyLight800 (1:10,000, Thermo Fisher Scientific) 
were used and visualized with the Odyssey Infrared Imaging Sys-
tem (LI-COR). Linear adjustments to images were made using Im-
ageJ. Relative density from Western blot analysis was determined 
using Imaging Studio Lite.
BN-PAGE analysis
BN-PAGE was performed as previously described (Wittig et al., 
2006). Briefly, 200 µg mitochondria were suspended in 20  µl 
solubilization buffer (50  mM NaCl, 50  mM imidazole, 2  mM 
6-aminohexanoic acid, and 1 mM EDTA, pH 7.0), and membrane 
proteins were solubilized on ice for 10 min with Triton X-100 to 
a detergent/protein ratio of 2 g/g. After centrifugation (20 min 
at 20,000 g), the supernatant was collected, and protein concen-
trations were quantified by BCA. Glycerol was added to a final 
concentration of 5%, and Coomassie dye from a 5% Coomassie 
blue G-250 stock suspension was added to a final detergent/dye 
ratio of 8 g/g. An equal amount of protein (5 or 25 µg) was loaded 
and run on a 3.5–16% or 5–16% gel with 25 mM imidazole (pH 
7.0) as anode buffer and 50 mM Tricine, 7.5 mM imidazole, and 
0.02% Coomassie blue G-250 as cathode buffer. The cathode buf-
fer was changed to 50 mM Tricine, 7.5 mM imidazole, and 0.002% 
Coomassie blue G-250 after the protein had migrated through 
one-third of the resolving gel. Gels were run at 4°C at an initial 
voltage of 100 V. When the sample had reached the resolving gel, 
the voltage was increased to 200–250 V until the Coomassie dye 
approached the gel front. Native gels were incubated with agi-
tation for 20 min in 300 mM Tris, 100 mM acetic acid, and 1% 
SDS, pH 8.6. The gels were then placed between two glass plates 
for 1 h at RT to allow the SDS to spread evenly within the gel and 
denature the protein. Proteins were then electroblotted on PVDF 
membrane at 4°C for 12 h using SDS-free transfer buffer (150 mM 
Tris and 50 mM acetic acid, pH 8.6). Proteins were transferred at 
90 mA and voltage limited to 20 V.
Quantification and statistical analysis
To quantify domain area (µm2) and domain intensity/area (AU/
µm2), background subtraction, threshold, and watershed were 
performed using max z-projections in ImageJ of images taken 
under all the same imaging conditions for each experiment. Par-
ticles were analyzed from threshold and watershed 488-channel 
images with size (0.05–2.0, 0.4–2.0) and circularity (0.4–1.0) 
for yeast and mammalian cells, respectively. Regions of interest 
identified from particle analysis were selected on the original 
image and measured for particle area (µm2) and integrated den-
sity (AU). Particle area was averaged for each experiment. The 
integrated density with the background subtracted was divided 
by the corresponding particle area to determine the intensity/
area and averaged for each experiment. At least 70 cells were 
quantified and imaged for three separate experiments.
To quantify the corrected total cell fluorescence, cells were 
outlined from single-plane bright-field images, and the inte-
grated density was determined using the sum of z-projections 
using ImageJ. The integrated density – (area of selected cell × 
mean fluorescence of background readings) was determined and 
averaged for at least 70 cells per experiment.
All statistical analyses were performed using R version 3.4.4. 
One-way ANO VA analyses were followed by post hoc pairwise 
t test with Bonferroni correction. Normality of residuals was 
tested by visual inspection of Q-Q plots followed by Shapiro–Wilk 
tests. Homoscedasticity was tested with a Levene test. When 
ANO VA assumptions were violated, a nonparametric Kruskal–
Wallis test was used followed by a post-hoc Dunn test. Analyses 
with P values smaller than 0.05 were considered significant.
Online supplemental material
Fig. S1 shows functional analysis of Coq-GFP strains as assessed 
by serial dilutions on fermentable carbon source containing 
media and CoQ lipid abundance measurements and also shows 
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the specificity of anti-Coq9 antibody in human cells. Fig. S2 
shows that CoQ production and CoQ domain distribution were 
affected in yeast cells expressing hypomorphic Coq5-yEGFP 
and also shows indirect immunofluorescence of fixed yeast 
cells of select Coq proteins. Fig. S3 shows CoQ lipid measure-
ments and the percentage of cells with CoQ domains as a func-
tion of time in COQ6 G386A N388D cells after VA addition and 
in COQ8 AS cells following addition of CMK. Fig. S4 contains 
BN-PAGE analysis showing the presence of large molecular 
Coq9-containing species correlated with CoQ domains in cells. 
Fig. S5 shows that CoQ domains were present in LTC-deficient 
cells and also shows CoQ lipid abundance measurements for 
LTC-deficient cells.
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